Matches in Wikidata for { <http://www.wikidata.org/entity/Q66040804> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66040804 description "clinical trial" @default.
- Q66040804 description "ensayu clínicu" @default.
- Q66040804 description "klinisch onderzoek" @default.
- Q66040804 description "клінічне випробування" @default.
- Q66040804 name "A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients" @default.
- Q66040804 name "A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients" @default.
- Q66040804 type Item @default.
- Q66040804 label "A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients" @default.
- Q66040804 label "A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients" @default.
- Q66040804 prefLabel "A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients" @default.
- Q66040804 prefLabel "A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients" @default.
- Q66040804 P1132 Q66040804-1667A4EB-2C45-4C84-99F0-16654206F0FC @default.
- Q66040804 P131 Q66040804-288A596D-3EE9-4441-8BC4-31DF002C0A19 @default.
- Q66040804 P1476 Q66040804-09AF2A02-C712-4B14-98FC-79104F3C5B68 @default.
- Q66040804 P17 Q66040804-4E138200-36EA-4621-A5AF-F347C267E99C @default.
- Q66040804 P2899 Q66040804-E0C2B97F-439A-472B-9352-BDF53B669184 @default.
- Q66040804 P3098 Q66040804-313F0875-CBBE-419F-9174-8ABF0E7278F5 @default.
- Q66040804 P31 Q66040804-8E508A47-977B-41F2-8C56-E313A723E68C @default.
- Q66040804 P4844 Q66040804-6CA2AD33-01EB-4999-948F-00A3D6C64988 @default.
- Q66040804 P4844 Q66040804-7AFD6B20-8B28-42FC-9566-33CF7ABF5444 @default.
- Q66040804 P4844 Q66040804-8194B49B-7825-4ADF-B75B-19CA89187EB0 @default.
- Q66040804 P6099 Q66040804-ACBD492B-7C07-42A7-B007-F7A3D2085215 @default.
- Q66040804 P6153 Q66040804-0486481C-476B-4B56-97EE-171E1FF394C0 @default.
- Q66040804 P6153 Q66040804-8623573B-1161-4F38-8BFA-CC42F659D245 @default.
- Q66040804 P6153 Q66040804-D1D77CF3-0753-4E5F-9098-D676AC394321 @default.
- Q66040804 P6153 Q66040804-DAC5C17C-11FE-463E-84A7-A2E1FEF8559D @default.
- Q66040804 P8363 Q66040804-05224B52-2108-4BEF-B12C-63FBA61CB012 @default.
- Q66040804 P1132 "+475" @default.
- Q66040804 P131 Q1183 @default.
- Q66040804 P1476 "A Phase II, Randomized Trial of Amprenavir as Part of Dual Protease Inhibitor Regimens (Placebo-Controlled) in Combination With Abacavir, Efavirenz, and Adefovir Dipivoxil Versus Amprenavir Alone in HIV-Infected Subjects With Prior Exposure to Approved Protease Inhibitors and Loss of Virologic Suppression as Reflected by a Plasma HIV-1 RNA Concentration >= 1,000 Copies/ml" @default.
- Q66040804 P17 Q30 @default.
- Q66040804 P2899 "+13" @default.
- Q66040804 P3098 "NCT00000912" @default.
- Q66040804 P31 Q30612 @default.
- Q66040804 P4844 Q304330 @default.
- Q66040804 P4844 Q425490 @default.
- Q66040804 P4844 Q50315992 @default.
- Q66040804 P6099 Q42824440 @default.
- Q66040804 P6153 Q149990 @default.
- Q66040804 P6153 Q168751 @default.
- Q66040804 P6153 Q238101 @default.
- Q66040804 P6153 Q7896167 @default.
- Q66040804 P8363 Q78089383 @default.